Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 1;102(10):3739-3748.
doi: 10.1210/jc.2016-3476.

Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence

Barbara A Cohn  1 , Piera M Cirillo  1 , Bill R Hopper  1 , Pentti K Siiteri  1
Affiliations

Third Trimester Estrogens and Maternal Breast Cancer: Prospective Evidence

Barbara A Cohn et al. J Clin Endocrinol Metab. .

Abstract

Context: Full-term pregnancy is associated with a transient increase and life-time decrease in maternal breast cancer risk. Estrone (E1), estradiol (E2), and estriol (E3) are in high concentration during the third trimester. E1 and E2 metabolism produces carcinogenic intermediaries, and E3 metabolism does not.

Objective: We tested the hypothesis that higher E3 in pregnancy is protective while higher E1 plus E2 increases risk.

Design: Prospective case-cohort study (n = 620; 204 cases) nested in a 38-year follow-up of 15,528 pregnant women in the Child Health and Development Studies. We measured E1, E2, and E3 in archived third trimester serum and estimated associations with breast cancer.

Setting: Northern California Kaiser members receiving obstetric care from 1959 to 1967.

Main outcome measure: Breast cancer diagnosed through 1997.

Results: Doubling of E1+E2 was associated with greater risk [hazard ratio (HR), 1.7; 95% confidence interval (CI), 1.2 to 2.4]. In contrast, doubling of E3 or the E3/E1+E2 ratio was associated with protection (HR, 0.7; 95% CI, 0.5 to 1.0; HR, 0.6; 95% CI, 0.4 to 0.8, respectively). Associations were stronger for diagnoses within 15 years after delivery compared with 16 to 38 years (Pinteraction = 0.0002) for gravidas >27 years at delivery vs ≤27 (Pinteraction = 0.01) and for primiparas vs multiparas (Pinteraction = 0.02).

Conclusions: Relatively high third trimester E3 levels might protect parous women from breast cancer and E1 and E2 might enhance the risk. If findings are confirmed, third trimester pregnancy estrogens could help explain how parity affects breast cancer.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
E1, E2, and E3 stratified by day of gestation. “X” represents measured levels. Solid circles represent fitted values from LOESS regression.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lemon HM, Wotiz HH, Parsons L, Mozden PJ. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. JAMA. 1966;196(13):1128–1136. - PubMed
    1. Siiteri PK. The continuing saga of dehydroepiandrosterone (DHEA). J Clin Endocrinol Metab. 2005;90(6):3795–3796. - PubMed
    1. Santen RJ, Brodie H, Simpson ER, Siiteri PK, Brodie A. History of aromatase: saga of an important biological mediator and therapeutic target. Endocr Rev. 2009;30(4):343–375. - PubMed
    1. Resnik R, Killam AP, Battaglia FC, Makowski EL, Meschia G. The stimulation of uterine blood flow by various estrogens. Endocrinology. 1974;94(4):1192–1196. - PubMed
    1. Yager JD. Mechanisms of estrogen carcinogenesis: the role of E2/E1-quinone metabolites suggests new approaches to preventive intervention—a review. Steroids. 2015;99(Pt A):56–60. - PMC - PubMed

Publication types